Biblio

[ Author(Asc)] Title Type Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
P
Peng K, Xie W, Wang T, Li Y, Habimana Jde Dieu, Amissah OBoadi, Huang J, Chen Y, Ni B, Li Z. HIF-1α promotes kidney organoid vascularization and applications in disease modeling. Stem Cell Res Ther. 2023;14(1):336.
Peng Q, Tao J, Xu Y, Shen Y, Wang Y, Jiao Y, Mao Y, Zhu Y, Liu Y, Tian Y. Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. Transl Oncol. 2023;39:101828.
Peng M, Chu X, Peng Y, Li D, Zhang Z, Wang W, Zhou X, Xiao D, Yang X. Targeted therapies in bladder cancer: signaling pathways, applications, and challenges. MedComm (2020). 2023;4(6):e455.
Peng Y, Chen X, Zhang Q, Liu S, Wu W, Li K, Lin H, Qing X, Xiao Y, Wang BC, et al. Enzymatically Bioactive Nucleus Pulposus Matrix Hydrogel Microspheres for Exogenous Stem Cells Therapy and Endogenous Repair Strategy to Achieve Disc Regeneration. Adv Sci (Weinh). 2023:e2304761.
Peng D, Jackson D, Palicha B, Kernfeld E, Laughner N, Shoemaker A, Celniker SE, Loganathan R, Cahan P, Andrew DJ. Organogenetic transcriptomes of the Drosophila embryo at single cell resolution. Development. 2024.
Peng Z, Ludke A, Wu J, Li S, Alibhai FJ, Zhang Y, Fan Y, Song H, He S, Xie J, et al. Uterine immunoprivileged cells restore cardiac function of male recipients after myocardial infarction. Stem Cells. 2024.
Peng Y-W, Tang R, Xu Q-Y, Mei S-Y, Zhou Y, Feng J-H, Zhang S-Y, He Z-Y. Worldwide productivity and research trend of publications concerning extracellular vesicles role in fibrosis: A bibliometric study from 2013 to 2022. Heliyon. 2024;10(2):e24357.
Peng Z, Wang S, Wen D, Mei Z, Zhang H, Liao S, Lv L, Li C. FEN1 upregulation mediated by SUMO2 via antagonizing proteasomal degradation promotes hepatocellular carcinoma stemness. Transl Oncol. 2024;44:101916.
Peng L, Luan S, Shen X, Zhan H, Ge Y, Liang Y, Wang J, Xu Y, Wu S, Zhong X, et al. Thyroid hormone deprival and tsh/tshr signaling deficiency lead to central hypothyroidism-associated intestinal dysplasia. Life Sci. 2024:122577.
Peng L, Chen J-W, Chen Y-Z, Zhang C, Shen S-H, Liu M-Z, Fan Y, Yang S-Q, Zhang X-Z, Wang W, et al. UPK3A umbrella cell damage mediated by TLR3-NR2F6 triggers programmed destruction of urothelium in Hunner-type interstitial cystitis/painful bladder syndrome. J Pathol. 2024.
Peng Y, Zheng W, Chen Y, Lei X, Yang Z, Yang Y, Liang W, Sun K, Li G, Yu J. POLQ inhibition attenuates the stemness and ferroptosis resistance in gastric cancer cells via downregulation of dihydroorotate dehydrogenase. Cell Death Dis. 2024;15(4):248.
Peng Y, Huang J, Yin J, Meng F, Cao Y, Huang L, Li D, Zhang Y, Zhang D, Meng L, et al. Frontline combination of dasatinib and low-intensity chemotherapy in adults with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia. Expert Rev Hematol. 2024.
Penfold CA, Sybirna A, Reid JE, Huang Y, Wernisch L, Ghahramani Z, Grant M, M Surani A. Branch-recombinant Gaussian processes for analysis of perturbations in biological time series. Bioinformatics. 2018;34(17):i1005-i1013.
Penfold CA, Gherman I, Sybirna A, Wild DL. Inferring Gene Regulatory Networks from Multiple Datasets. Methods Mol Biol. 2019;1883:251-282.
Penfold L, Woods A, Pollard AE, Arizanova J, Pascual-Navarro E, Muckett PJ, Dore MH, Montoya A, Whilding C, Fets L, et al. AMPK activation protects against prostate cancer by inducing a catabolic cellular state. Cell Rep. 2023;42(4):112396.
Penel N, Ray-Coquard I, Bal-Mahieu C, Chevreau C, Le Cesne A, Italiano A, Bompas E, Clisant S, Baldeyrou B, Lansiaux A, et al. Low level of baseline circulating VEGF-A is associated with better outcome in patients with vascular sarcomas receiving sorafenib: an ancillary study from a phase II trial. Target Oncol. 2013.
Peñarando J, Aranda E, Rodríguez-Ariza A. Immunomodulatory roles of nitric oxide in cancer: tumor microenvironment says "NO" to antitumor immune response. Transl Res. 2019.
Peñaflor-Juárez K, Guillén-Chan SMarilyn, Romero-Juárez Y, Luna-Bautista F, Franco-Gutiérrez E, Arellano-Ocampo JSalvador, Ibáñez-Sánchez R, Domínguez-Contreras MDe Lourdes, Guerra-Márquez A. [The cord blood bank at the Instituto Mexicano del Seguro Social]. Rev Med Inst Mex Seguro Soc. 2015;53 Suppl 1:S94-S99.
Penack O, Tridello G, Hoek J, Socié G, Blaise D, Passweg J, Chevallier P, Craddock C, Milpied N, Veelken H, et al. Influence of pre-existing invasive aspergillosis on allo-HSCT outcome: a retrospective EBMT analysis by the Infectious Diseases and Acute Leukemia Working Parties. Bone Marrow Transplant. 2015.
Penack O, Marchetti M, Ruutu T, Aljurf M, Bacigalupo A, Bonifazi F, Ciceri F, Cornelissen J, Malladi R, Duarte RF, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation. Lancet Haematol. 2020;7(2):e157-e167.
Penack O, Peczynski C, Mohty M, Yakoub-Agha I, de la Camara R, Glass B, Duarte RF, Kröger N, Schoemans H, Koenecke C, et al. Association of pre-existing comorbidities with outcome of allogeneic hematopoietic cell transplantation. A retrospective analysis from the EBMT. Bone Marrow Transplant. 2021.
Penack O, Peczynski C, Koenecke C, Polge E, Kuhnl A, Fegueux N, Daskalakis M, Kröger N, Dreger P, Besley C, et al. Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. J Immunother Cancer. 2023;11(4).
Penack O, Peczynski C, Koenecke C, Polge E, Sanderson R, Yakoub-Agha I, Fegueux N, Daskalakis M, Collin M, Dreger P, et al. Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party. Front Immunol. 2023;14:1252811.
Penack O, Peczynski C, Boreland W, Lemaitre J, Afanasyeva K, Kornblit B, Jurado M, Martínez C, Natale A, Pérez-Simón JAntonio, et al. ECP versus ruxolitinib in steroid-refractory acute GVHD - a retrospective study by the EBMT transplant complications working party. Front Immunol. 2023;14:1283034.
Penack O, Peczynski C, Boreland W, Lemaitre J, H Reinhardt C, Afanasyeva K, Avenoso D, Holderried TAW, Kornblit BThomas, Gavriilaki E, et al. ECP versus ruxolitinib in steroid-refractory chronic GVHD - a retrospective study by the EBMT transplant complications working party. Bone Marrow Transplant. 2024.

Pages